Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI
NCT02794402
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Obesity
Interventions
DRUG:
Exenatide
BEHAVIORAL:
Placebo
Sponsor
Uppsala University